Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study.

Mahmoudi Y, Badali H, Hashemi SM, Ansari M, Fakhim H, Fallah M, Shokrzadeh M, Emami S.

Bioorg Chem. 2019 Sep;90:103060. doi: 10.1016/j.bioorg.2019.103060. Epub 2019 Jun 12.

PMID:
31229796
2.

In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra.

Badali H, Al-Hatmi AMS, Fakhim H, Moghaddasi A, Khodavaisy S, Vaezi A, Ahangarkani F, de Hoog GS, Meis JF.

Int J Antimicrob Agents. 2019 Jul;54(1):95-98. doi: 10.1016/j.ijantimicag.2019.05.006. Epub 2019 May 7.

PMID:
31071468
3.

Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients.

Nasri E, Fakhim H, Vaezi A, Khalilzadeh S, Ahangarkani F, Laal Kargar M, Abtahian Z, Badali H.

Mycoses. 2019 May;62(5):434-440. doi: 10.1111/myc.12898. Epub 2019 Mar 13.

PMID:
30681747
4.

Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections.

Vaezi A, Fakhim H, Abtahian Z, Khodavaisy S, Geramishoar M, Alizadeh A, Meis JF, Badali H.

Front Microbiol. 2018 Oct 12;9:2434. doi: 10.3389/fmicb.2018.02434. eCollection 2018. Review.

5.

Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism.

Pakshir K, Fakhim H, Vaezi A, Meis JF, Mahmoodi M, Zomorodian K, Javidnia J, Ansari S, Hagen F, Badali H.

J Mycol Med. 2018 Dec;28(4):599-605. doi: 10.1016/j.mycmed.2018.09.005. Epub 2018 Oct 12.

PMID:
30322827
6.

Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles.

Diba K, Makhdoomi K, Nasri E, Vaezi A, Javidnia J, Gharabagh DJ, Jazani NH, Reza Chavshin A, Badiee P, Badali H, Fakhim H.

Microb Pathog. 2018 Dec;125:240-245. doi: 10.1016/j.micpath.2018.09.026. Epub 2018 Sep 18.

PMID:
30240817
7.

Discovery of benzylthio analogs of fluconazole as potent antifungal agents.

Motahari K, Badali H, Hashemi SM, Fakhim H, Mirzaei H, Vaezi A, Shokrzadeh M, Emami S.

Future Med Chem. 2018 May 1;10(9):987-1002. doi: 10.4155/fmc-2017-0295. Epub 2018 Apr 23.

PMID:
29683339
8.

In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.

Fakhim H, Vaezi A, Dannaoui E, Sharma C, Mousavi B, Chowdhary A, Meis JF, Badali H.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):266-268. doi: 10.1016/j.diagmicrobio.2018.03.003. Epub 2018 Mar 8.

PMID:
29622284
9.

Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?

Vaezi A, Fakhim H, Javidnia J, Khodavaisy S, Abtahian Z, Vojoodi M, Nourbakhsh F, Badali H.

J Mycol Med. 2018 Mar;28(1):59-64. doi: 10.1016/j.mycmed.2017.12.007. Epub 2018 Feb 27.

PMID:
29496370
10.

Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.

Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H.

Mycoses. 2018 Jun;61(6):377-382. doi: 10.1111/myc.12754. Epub 2018 Mar 14.

PMID:
29460345
11.

Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran.

Falahatinejad M, Vaezi A, Fakhim H, Abastabar M, Shokohi T, Zahedi N, Ansari S, Meis JF, Badali H.

Mycoses. 2018 Feb;61(2):143-147. doi: 10.1111/myc.12717. Epub 2017 Nov 22.

PMID:
29064130
12.

In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.

Vaezi A, Fakhim H, Arastehfar A, Shokohi T, Hedayati MT, Khodavaisy S, Rezaei-Matehkolaei A, Badiee P, Hagen F, Lass-Flörl C, Dannaoui E, Meis JF, Badali H.

Mycoses. 2018 Feb;61(2):134-142. doi: 10.1111/myc.12716. Epub 2017 Nov 22.

PMID:
29064123
13.

Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus.

Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, Bragulat MR, Cabañes FJ, Carbia M, Chakrabarti A, Chaturvedi S, Chaturvedi V, Chen M, Chowdhary A, Colom MF, Cornely OA, Crous PW, Cuétara MS, Diaz MR, Espinel-Ingroff A, Fakhim H, Falk R, Fang W, Herkert PF, Ferrer Rodríguez C, Fraser JA, Gené J, Guarro J, Idnurm A, Illnait-Zaragozi MT, Khan Z, Khayhan K, Kolecka A, Kurtzman CP, Lagrou K, Liao W, Linares C, Meis JF, Nielsen K, Nyazika TK, Pan W, Pekmezovic M, Polacheck I, Posteraro B, de Queiroz Telles F Filho, Romeo O, Sánchez M, Sampaio A, Sanguinetti M, Sriburee P, Sugita T, Taj-Aldeen SJ, Takashima M, Taylor JW, Theelen B, Tomazin R, Verweij PE, Wahyuningsih R, Wang P, Boekhout T.

mSphere. 2017 Aug 30;2(4). pii: e00238-17. doi: 10.1128/mSphere.00238-17. eCollection 2017 Jul-Aug.

14.

In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, Badali H.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01056-17. doi: 10.1128/AAC.01056-17. Print 2017 Nov.

15.

Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis.

Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, Boekhout T, Badali H.

J Mycol Med. 2017 Jun;27(2):146-152. doi: 10.1016/j.mycmed.2017.02.007. Epub 2017 Mar 16. Review.

PMID:
28318900
16.

Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature.

Rezai MS, Vaezi A, Fakhim H, Soleimani A, Mohammad Jafari H, Mohseni S, Badali H.

J Mycol Med. 2017 Jun;27(2):261-265. doi: 10.1016/j.mycmed.2017.01.006. Epub 2017 Feb 8. Review.

PMID:
28188050
17.

In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.

Fakhim H, Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K, Dannaoui E, Badali H.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01106-16. doi: 10.1128/AAC.01106-16. Print 2017 Jan.

18.

In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.

Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H.

Mycopathologia. 2016 Apr;181(3-4):235-40. doi: 10.1007/s11046-015-9968-0. Epub 2015 Nov 28.

PMID:
26615417
19.

Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature.

Badali H, Alian S, Fakhim H, Falahatinejad M, Moradi A, Mohammad Davoudi M, Hagen F, Meis JF.

Mycoses. 2015 Dec;58(12):689-93. doi: 10.1111/myc.12415. Epub 2015 Oct 7. Review.

PMID:
26444438
20.

In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.

Badali H, Khodavaisy S, Fakhim H, de Hoog GS, Meis JF, Chowdhary A.

Antimicrob Agents Chemother. 2015 Dec;59(12):7818-22. doi: 10.1128/AAC.01733-15. Epub 2015 Sep 14.

21.

Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis.

Yazdanparast SA, Khodavaisy S, Fakhim H, Shokohi T, Haghani I, Nabili M, Gholami H, Ahmadi I, Badali H.

Mycopathologia. 2015 Dec;180(5-6):317-23. doi: 10.1007/s11046-015-9924-z. Epub 2015 Jul 17.

PMID:
26183965
22.

The first case of onychomycosis due to Aspergillus uvarum (section Nigri).

Zarei F, Mirhendi H, Fakhim H, Geramishoar M.

Mycoses. 2015 Apr;58(4):239-42. doi: 10.1111/myc.12304. Epub 2015 Feb 27. No abstract available.

PMID:
25728245
23.

Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD).

Khodavaisy S, Mortaz E, Mohammadi F, Aliyali M, Fakhim H, Badali H.

Curr Med Mycol. 2015 Mar;1(1):42-48. doi: 10.18869/acadpub.cmm.1.1.42. Review.

Supplemental Content

Loading ...
Support Center